NCT05593549View on ClinicalTrials.gov

Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Type 2 DiabetesHealthy Aging
Interventions
DRUG

Trehalose

Trehalose will be given at a dose of 10g mixed in 500 mL of water to be consumed 1 time per day for 14 days

DRUG

Placebo

Microcrystalline cellulose will be given at a dose of 10g mixed in 500 mL of water to be consumed 1 time per day for 14 days

Trial Locations (1)

53226

RECRUITING

Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER